Innovation

The State of the Financial Ecosystem: The Evolving Venture Model

53 min.

Clinical Research Areas and Funding

10 min.

Government Policies and Preferences

12 min.

Diversity and Inclusion: Implications for RCTs and Work Force Considerations

35 min.

FDA and Diversity Initiatives

8 min.

Clinician Perspectives

9 min.

Industry Perspectives

9 min.

Overcoming the "Credibility Crisis" of Observational Data

13 min.

FDA Perspectives

8 min.

The FDA Total lifecycle Advisory Program (FDA-TAP)

36 min.

Understanding the New Technology Add-on Payments Program (NTAP)

9 min.

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

10 min.

The Projected Burden of Heart Failure

8 min.

Are All Incentives Altruistic?: The Importance of Measurement

8 min.

Medicare Coverage and Postmarket Evidence on Emerging Cardiovascular Devices

8 min.

Who Bears the Cost of Innovation?

9 min.

A Payors Perspective: Innovative Models to Reduce Cost

9 min.